We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SLS market cap is 73.2M. The company's latest EPS is USD -0.5305 and P/E is -1.96.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.36M | -8.18M | -9.65M | -7.62M | -7.33M |
| Net Income | -9.27M | -8.14M | -9.57M | -7.47M | -7.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.9M | 7.6M | 1M | 0 |
| Operating Income | -20.04M | -16.98M | -19.59M | -41.95M | -37.87M |
| Net Income | -27.95M | -16.76M | -20.7M | -41.3M | -37.34M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.09M | 6.22M | 24.43M | 15.12M | 26.51M |
| Total Liabilities | 11.91M | 14.2M | 14.75M | 12.21M | 10.61M |
| Total Equity | -3.83M | -7.98M | 9.68M | 2.91M | 15.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.61M | 46.05M | 26.28M | 20.94M | 6.22M |
| Total Liabilities | 10.52M | 18.09M | 5.93M | 16.09M | 14.2M |
| Total Equity | 6.09M | 27.96M | 20.35M | 4.85M | -7.98M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.59M | -31.41M | -10.76M | -20.44M | -28.25M |
| Investing | -5.5M | -5.5M | N/A | N/A | N/A |
| Financing | 18.93M | 22.32M | 26.65M | 27.06M | 46.75M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.64M | -10.42M | -26.02M | -23.81M | -31.41M |
| Investing | N/A | N/A | N/A | -4.5M | -5.5M |
| Financing | 19.57M | 38.44M | 12.07M | 24.08M | 22.32M |
| Market Cap | 73.2M |
| Price to Earnings Ratio | -1.96 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 28.97 |
| Price to Book Ratio | -9.18 |
| Dividend Yield | - |
| Shares Outstanding | 70.38M |
| Average Volume (1 week) | 1.51M |
| Average Volume (1 Month) | 1.52M |
| 52 Week Change | 80.87% |
| 52 Week High | 1.72 |
| 52 Week Low | 0.4986 |
| Spread (Intraday) | 0.01 (0.95%) |
| Company Name | SELLAS Life Sciences Group Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sellaslifesciences.com/home/default.aspx |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
